Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice

Inflammopharmacology

Volumn 14, Issue 5-6, 2006, Pages 222-225

  Dhir, A ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Brain; COX 2 inhibitors; Cyclooxygenase; Epilepsy; Rofecoxib; Tiagabine

Indexed keywords

PENTETRAZOLE; ROFECOXIB; TIAGABINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; CLONUS; CONFERENCE PAPER; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; GABAERGIC TRANSMISSION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICONVULSANTS; CYCLOOXYGENASE 2 INHIBITORS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; LACTONES; MALE; MICE; NIPECOTIC ACIDS; PENTYLENETETRAZOLE; SEIZURES; SULFONES;

EID: 33845863671     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-006-1535-3     Document Type: Conference Paper

References (30)

1. Ahuja, N., Singh, A., Singh, B. (2003). Rofecoxib, an update on physicochemical, pharmaceutical, pharmacodynamic and pharmacokinetic aspects. J. Pharm. Pharmacol. 55, 859-894.
2. Allan, S. M., Rothwell, N. J. (2001). Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2, 734-744.
3. Baik, E. J., Kim, E. K., Lee S. H., Moon, C. (1999). Cyclooxygenase-2 selective inhibitors aggravate kainic acid induced seizures and neuronal cell death in the hippocampus. Brain Res. 843, 118-129.
4. Bazan, N. G. (2003). Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activationg factor. J. Lipid Res. 44, 2221-2233.
5. Braestrup, C., Nielsen, E. B., Sonnewald, U. et al. (1990). NO-328 binds with high affinity to the brain GABA uptake carrier. J. Neurochem. 54, 639-645.
6. Dhir, A., Naidu, P. S., Kulkarni, S. K. (2005). Protective effect of naproxen, a non-selective COX-inhibitor on PTZ-induced kindling in mice. Clinical and Experimental Pharmacology and Physiology 32, 574-584.
7. Dhir, A., Naidu, P. S., Kulkarni, S. K. (2006a). Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)-induced convulsions, possible mechanism of action. Progress in Neuropsychopharmacology and Biological Psychiatry (in Press).
8. Dhir, A., Naidu, P. S., Kulkarni, S. K. (2006b). Effect of cyclooxygenase inhibitors on various animal models (picrotoxin, bicuculine and maximal electroshock-induced convulsions, possible GABAergic mechanism of action. Indian Journal of Experimental Biology 44, 286-291.
9. Dhir, A., Naidu, P. S., Kulkarni, S. K. (2006c). Effect of rofecoxib, a cyclooxygenase-2 (COX-2) inhibitor, on various biochemical parameters of brain associated with pentylenetetrazol (PTZ)-induced chemical kindling in mice" Fundamental and Clinical Pharmacology 20, 255-261.
10. Dickie, B. G., Annals, S. J., Davies, J. A. (1994). Effect of cyclooxygenase inhibition upon glutamate release from rat cerebellum. Neuroreport 5, 393-396.
11. nd edition, 21-33.
12. Griffin, M. R. (1999). Epidemology of nonsteroidal anti-inflammatory drug associated gastrointestinal injury. Am. J. Med. 104, 155-158.
13. Haris, R. H., Ramwell, P. W. (1979). Cellular mechanism of prostaglandin action. Ann. Rev. Physiol. 41, 653-658.
14. Hjalmar, B. S., George, H. (1981). Lowering of the convulsive threshold by non-steroidal anti-inflammatory drugs. European Journal of Pharmacology 69, 199-203.
15. Jain, N. K., Kulkarni, S. K., Singh, A. (2001). Lipopolysaccharide- mediated immobility in mice, reversal by cyclooxygenase enzyme inhibitor, Method Find. Exp. Clin. Pharmacol. 23, 441-444.
16. Kaminski, R., Kozicka, M., Parada-Turska, J., Dziki, M., Kleinrok, Z., Turski, W. A., Czuczwar, S. J. (1998). Effect of Non-Steroidal Anti-Inflammatory drugs on the anticonvulsive profile of valproate and diphenylhydantoin against maximal electroshock-induced seizures in mice. Pharmacol. Res. 37, 375-381.
17. Kawaguchi, K., Hickey, R. W., Rose, M. E., Zhu, L., Chen, J., Graham, S. H. (2005). Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus. Brain Res. 1050, 130-137.
18. Kim, E. J., Lee, J. E., Kwom, K. J., Lee, S. H., Moon, C. H., Baik, E. J. (2001). Differential role of cyclooxygenase isoforms after kainic acid-induced prostaglandins E(2) production and neurodegeneration in cortical and hippocampal cell cultures. Brain Res. 908, 1-9.
19. rd Edition, 133-134.
20. Kunz, T., Oliw, E. H. (2001). The selective cyclooxygenase-2 inhibitor rofecoxib reduces kainate-induced cell death in the rat hippocampus. Eur. J. Neurosci. 13, 569-575.
21. Minghetti, L. (2004). Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases. Journal of Neuropathology and Experimental Neurology 63, 901-910.
22. Nielsen E. B., Suzdak P. D., Andersen K. E. et al. (1991). Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor. Eur. J. Pharmacol. 196, 257-272.
23. ψ-Nitro-L- Arginine Methyl ester and Indomethacin reduces the elevation of brain PGE2 content and prevents seizures and hippocampal damage evoked by Licl and tacrine in rat. Experim. Neurol. 149, 349-355.
24. Picardo, A., Gent, J. P., Feely, M. (1990). Anticonvulsant tolerance and recovery during repeated administration of the GABA uptake inhibitor NO-328. Br. J. Pharmacol. 99, 131P.
25. Shafiq, N., Malhotra, S., Pandhi, P. (2003). Anticonvulsant action of celecoxib (alone and in combination with sub-threshold dose of phenytoin) in electroshock induced convulsions. Methods Find. Exp. Clin. Pharmacol. 25, 87-90.
26. Sujdak, P. D., Jansen, J. A. (1995). A Review of the Preclinical Pharmacology of Tiagabine, a Potent and Selective Anticonvulsant GABA Uptake Inhibitor. Epilepsia 36, 612-626.
27. Takemiya, T., Suzuki, K., Sugiura, H., Yasuda, S., Yamagata, K., Kawakami, Y., Maru, E. (2003). Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins & Other Lipid Medi. 71, 205-216.
28. Tandon, M., Anuradha, K., Pandhi, P. (2003). Evaluation of antiepileptic activity of aspirin in combination with newer antiepileptic lamotrigine in mice. Method Find. Exp. Clin. Pharmacol. 25, 607-610.
29. Vezzani, A. (2005). Inflammation and Epilepsy. Epilepsy Curr. 5, 1-6.
30. Voutsinos-Porche, B., Koning, E., Kaplan, H., Ferrandon, A., Guenouno, U. M., Nehlig, A., Motte, J. (2004). Temporal patterns of the cerebral inflammatory response in the rat lithium pilocarpine model of temporal lobe epilepsy. Neurobiol. Dis. 17, 385-402.